View Older Stories
-
Align Technology (ALGN) Tops Q4 EPS by 32c; offers guidance
-
Piper Sandler Reiterates Overweight Rating on Align Technology (ALGN)
-
Align Technology's (ALGN) Direct Fab Will Be Quite Favourable in 2028 - Stifel
-
Stifel: 'we started hearing chatter that Angelalign was going to soon implement a price increase on its clear aligners'
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Align Technology (ALGN) PT Raised to $200 at Piper Sandler
-
Needham Reiterates Hold Rating on Align Technology (ALGN)
-
Align Technology (ALGN) PT Raised to $189 at Leerink Partners
-
After-hours movers: Meta, Microsoft, Alphabet, Starbucks and more
-
Align Technology (ALGN) Tops Q3 EPS by 19c
-
Align Technology unveils new iTero digital scanner features
-
Align Technology launches automated Invisalign treatment planning feature
-
Piper Sandler on Align Technology (ALGN): 'Improvement with Breadth, Constructive View Ahead of 3Q'
-
Align Technology (ALGN) PT Lowered to $155 at UBS Amid Weak Sentiment
-
Align Technology (ALGN) PT Lowered to $170 at Mizuho
-
Jefferies Downgrades Align Technology (ALGN) to Hold
-
Align Technology files ITC complaint against Angelalign over clear aligners
-
Piper Sandler: 'Timely Turn of Aggression from Align Technology (ALGN)'
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Align Technology terminates HR executive effective May 2026
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Align Technology plans $200 million stock buyback program
-
Align Technology (ALGN) call put ratio 1 call to 3.2 puts as share price down 36%
-
Johnson Fistel Commences Investigation of Align Technology, Inc.
-
Align Technology (ALGN) PT Lowered to $210 at Mizuho
-
Morgan Stanley Downgrades Align Technology (ALGN) to Equalweight
-
Align Technology (ALGN) PT Lowered to $200 at Stifel
-
After-hours movers: Meta Platforms, Microsoft, Align Technology and more
-
Align Technology (ALGN) Misses Q2 EPS by 8c ; Offers Guidance
-
Piper Sandler on Align Technology (ALGN): 'Positive Trend Reversal, We Like the Mosaic Ahead of 2Q'
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Align Technology (ALGN) Appoints Britt Vitalone to its Board
-
Piper Sandler Highlights 'Best Value Stocks' in Medical Technology
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Align Technology (ALGN) Announces New $1 Billion Stock Repurchase Program
-
Align Technology (ALGN) Tops Q1 EPS by 13c; offers guidance
-
Align Technology (ALGN) PT Lowered to $245 at Mizuho
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
HSBC Downgrades Align Technology (ALGN) to Hold
-
Align Technology (ALGN) Announces Commercial Availability of Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction for the United States
-
Piper Sandler: 'Align Technology (ALGN) Exiting 1Q on a Better Note; We Remain Buyers'
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Mizuho Reiterates Outperform Rating on Align Technology (ALGN)
-
Align Technology (ALGN) Announces Invisalign System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction
-
Align Technology (ALGN) PT Lowered to $250 at Mizuho
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Align Technology (ALGN) PT Lowered to $235 at Piper Sandler
-
Stifel Reiterates Buy Rating on Align Technology (ALGN)
-
Stifel highlights medical technology stocks with best risk/reward

